MediciNova Inc - Company Profile
Powered by 
All the data and insights you need on MediciNova Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date MediciNova Inc Strategy Report
- Understand MediciNova Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on MediciNova Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4346783A1 | Application | Phenoxyalkylcarbonsäurederivate und ihre verwendung zur senkung des triglyceridspiegels | A61K31/015; A61K31/192; A61K9/0053; A61P3/06; A61P3/08 | April 10, 2024 |
| ES2964286T3 | Grant | Método de tratamiento de la esteatohepatitis no alcohólica avanzada | A61K31/05; A61K31/075; A61K31/085; A61K31/095; A61K31/10; A61K31/121; A61K31/122; A61K9/0053; A61K9/08; A61K9/20; A61K9/48; A61P1/16; C07C323/22 | April 05, 2024 |
| US11944607B2 | Grant | Treatment of progressive neurodegenerative disease with ibudilast | A61K31/437; A61K45/06; A61K9/0014; A61K9/0019; A61K9/0053; A61K9/06 | April 02, 2024 |
| US11925625B2 | Grant | Methods of treating chemical gas exposure | A61K31/437; A61K31/56; A61P11/00 | March 12, 2024 |
| ES2959799T3 | Grant | Métodos para suprimir células supresoras de origen mieloide en pacientes | A61K31/437; A61K9/0053; A61P31/00; A61P35/00; A61P37/00 | February 28, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer